However, in EC NFκB plays a divergent role, as it may play a predominant pro-apoptotic role, induces the expression of anti-angiogenic factors and is involved in effectuating angiostatic therapy and increasing anti-tumor immunity [38]. The gene discussed is NFKB1; the disease is neoplasm.